vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.8倍（$13.7M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -10.3%，领先8.3%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -4.4%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-1.3M），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 1.9%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
CPIX vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $7.5M |
| 净利润 | $-1.4M | $-155.0K |
| 毛利率 | 83.6% | 34.0% |
| 营业利润率 | -10.0% | 1.1% |
| 净利率 | -10.3% | -2.1% |
| 营收同比 | 31.1% | -4.4% |
| 净利润同比 | 25.8% | 81.7% |
| 每股收益（稀释后） | $-0.09 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.7M | $7.5M | ||
| Q3 25 | $8.3M | $6.8M | ||
| Q2 25 | $10.8M | $6.4M | ||
| Q1 25 | $11.7M | $8.9M | ||
| Q4 24 | $10.4M | $7.9M | ||
| Q3 24 | $9.1M | $6.4M | ||
| Q2 24 | $9.8M | $6.4M | ||
| Q1 24 | $8.5M | $7.3M |
| Q4 25 | $-1.4M | $-155.0K | ||
| Q3 25 | $-1.9M | $-662.0K | ||
| Q2 25 | $-740.7K | $-324.0K | ||
| Q1 25 | $1.3M | $-2.9M | ||
| Q4 24 | $-1.9M | $-847.0K | ||
| Q3 24 | $-1.5M | $-722.0K | ||
| Q2 24 | $-1.1M | $-1.7M | ||
| Q1 24 | $-1.9M | $-1.6M |
| Q4 25 | 83.6% | 34.0% | ||
| Q3 25 | 88.1% | 23.6% | ||
| Q2 25 | 81.4% | 31.1% | ||
| Q1 25 | 87.8% | 10.8% | ||
| Q4 24 | 81.1% | 23.4% | ||
| Q3 24 | 85.4% | 31.8% | ||
| Q2 24 | 82.6% | 12.8% | ||
| Q1 24 | 81.5% | 24.3% |
| Q4 25 | -10.0% | 1.1% | ||
| Q3 25 | -23.7% | -7.0% | ||
| Q2 25 | -6.9% | -2.3% | ||
| Q1 25 | 11.0% | -30.3% | ||
| Q4 24 | -17.7% | -8.9% | ||
| Q3 24 | -18.6% | -14.3% | ||
| Q2 24 | -10.4% | -25.4% | ||
| Q1 24 | -22.0% | -21.7% |
| Q4 25 | -10.3% | -2.1% | ||
| Q3 25 | -23.4% | -9.7% | ||
| Q2 25 | -6.8% | -5.1% | ||
| Q1 25 | 10.7% | -32.5% | ||
| Q4 24 | -18.2% | -10.7% | ||
| Q3 24 | -17.0% | -11.3% | ||
| Q2 24 | -11.0% | -25.9% | ||
| Q1 24 | -22.9% | -21.9% |
| Q4 25 | $-0.09 | $-0.02 | ||
| Q3 25 | $-0.13 | $-0.09 | ||
| Q2 25 | $-0.05 | $-0.04 | ||
| Q1 25 | $0.08 | $-0.38 | ||
| Q4 24 | $-0.13 | $-0.11 | ||
| Q3 24 | $-0.11 | $-0.11 | ||
| Q2 24 | $-0.08 | $-0.26 | ||
| Q1 24 | $-0.14 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $6.0M |
| 总资产 | $76.8M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $11.4M | $641.0K | ||
| Q3 25 | $15.2M | $2.0M | ||
| Q2 25 | $16.1M | $893.0K | ||
| Q1 25 | $15.1M | $720.0K | ||
| Q4 24 | $18.0M | $1.1M | ||
| Q3 24 | $17.5M | $973.0K | ||
| Q2 24 | $17.3M | $637.0K | ||
| Q1 24 | $18.5M | $2.1M |
| Q4 25 | $24.9M | $6.0M | ||
| Q3 25 | $26.1M | $6.1M | ||
| Q2 25 | $28.0M | $6.7M | ||
| Q1 25 | $28.7M | $7.0M | ||
| Q4 24 | $22.9M | $9.8M | ||
| Q3 24 | $24.8M | $10.5M | ||
| Q2 24 | $26.3M | $9.0M | ||
| Q1 24 | $27.5M | $10.6M |
| Q4 25 | $76.8M | $20.7M | ||
| Q3 25 | $65.9M | $22.3M | ||
| Q2 25 | $67.9M | $20.1M | ||
| Q1 25 | $69.9M | $21.2M | ||
| Q4 24 | $75.6M | $21.6M | ||
| Q3 24 | $76.7M | $21.1M | ||
| Q2 24 | $78.5M | $19.0M | ||
| Q1 24 | $81.5M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-1.3M |
| 自由现金流率自由现金流/营收 | 0.0% | -16.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | — |
8季度趋势，按日历期对齐
| Q4 25 | $3.0K | $-1.2M | ||
| Q3 25 | $187.2K | $-488.0K | ||
| Q2 25 | $843.8K | $350.0K | ||
| Q1 25 | $3.9M | $1.2M | ||
| Q4 24 | $1.9M | $-2.1M | ||
| Q3 24 | $475.5K | $-3.5M | ||
| Q2 24 | $-855.7K | $-2.2M | ||
| Q1 24 | $-2.1M | $129.0K |
| Q4 25 | $3.0K | $-1.3M | ||
| Q3 25 | $163.4K | $-544.0K | ||
| Q2 25 | $817.3K | $182.0K | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $460.1K | $-4.6M | ||
| Q2 24 | $-862.8K | $-2.6M | ||
| Q1 24 | $-2.2M | $-352.3K |
| Q4 25 | 0.0% | -16.9% | ||
| Q3 25 | 2.0% | -8.0% | ||
| Q2 25 | 7.5% | 2.9% | ||
| Q1 25 | 32.9% | — | ||
| Q4 24 | 18.2% | — | ||
| Q3 24 | 5.1% | -72.6% | ||
| Q2 24 | -8.8% | -40.2% | ||
| Q1 24 | -25.6% | -4.9% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.1% | 6.5% | ||
| Q1 24 | 0.5% | 6.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
